Join
Live feed
·
PRReleasevia Quantisnow
Amylyx Pharmaceuticals Inc. logo

Amylyx Pharmaceuticals Announces Peer-Reviewed Publication of Phase 2 Open-Label HELIOS Trial Data for AMX0035 in The Journal of Clinical Investigation

ByQuantisnow·Wall Street's wire, on your screen.
AMLX· Amylyx Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AMLX (Amylyx Pharmaceuticals Inc.) and more on Quantisnow.